{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T10:34:19Z","timestamp":1700649259508},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.jclinepi.2009.01.006","type":"journal-article","created":{"date-parts":[[2009,4,7]],"date-time":"2009-04-07T09:26:24Z","timestamp":1239096384000},"page":"588-593","source":"Crossref","is-referenced-by-count":4,"title":["The Transnational study of oral contraceptive cardiovascular safety: history and science"],"prefix":"10.1016","volume":"62","author":[{"given":"Samy","family":"Suissa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jclinepi.2009.01.006_bib1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0010-7824(88)90088-1","article-title":"Alterations in the serum levels of gestodene and SHBG during 12 cycles of treatment with 30 micrograms ethinylestradiol and 75 micrograms gestodene","volume":"38","author":"Kuhl","year":"1988","journal-title":"Contraception"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0010-7824(89)90094-2","article-title":"Interaction with the pharmacokinetics of ethinylestradiol and progestogens contained in oral contraceptives","volume":"40","author":"Jung-Hoffmann","year":"1989","journal-title":"Contraception"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/pds.2630020104","article-title":"Three epidemiological studies in the low-dose oral contraceptive research programme: a coherent strategy","volume":"2","author":"Spitzer","year":"1993","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/pds.2630020105","article-title":"Trinational case-control study of oral contraceptives and health","volume":"2","author":"Spitzer","year":"1993","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/pds.2630020107","article-title":"A concurrent cohort study of oral contraceptive users from the VAMP research bank","volume":"2","author":"Lis","year":"1993","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/pds.2630020106","article-title":"The Saskathewan oral contraceptive cohort study of oral contraceptive use and cardiovascular risks","volume":"2","author":"Suissa","year":"1993","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib7","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/0895-4356(95)00516-1","article-title":"A multinational case-control study of cardiovascular disease and steroid hormone contraceptives. Description and validation of methods. World Health Organization Collaborative Study of Cardiovascular and Steroid Hormone Contraception","volume":"48","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/(SICI)1099-1557(199601)5:1<43::AID-PDS217>3.0.CO;2-M","article-title":"Interim review of the transnational case-control study of oral contraceptives and health: approved protocol revisions through September 1995","volume":"5","author":"Lewis","year":"1996","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.312.7023.83","article-title":"Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women","volume":"312","author":"Spitzer","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib10","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib11","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib12","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/bmj.312.7023.88","article-title":"Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women","volume":"312","author":"Lewis","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(97)00204-7","article-title":"Thromboembolic stroke in young women. A European case-control study on oral contraceptives. Transnational Research Group on Oral Contraceptives and the Health of Young Women","volume":"57","author":"Heinemann","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/oxfordjournals.humrep.a019224","article-title":"What are the risks of third-generation oral contraceptives? Are third-generation oral contraceptives safe?","volume":"11","author":"Rosenberg","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0010-7824(97)00119-4","article-title":"First-time use of newer oral contraceptives and the risk of venous thromboembolism","volume":"56","author":"Suissa","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/humrep\/15.4.817","article-title":"Recurrent use of newer oral contraceptives and the risk of venous thromboembolism","volume":"15","author":"Suissa","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0010-7824(96)00112-6","article-title":"The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women","volume":"54","author":"Lewis","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0010-7824(97)00118-2","article-title":"The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women","volume":"56","author":"Lewis","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib20","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/humrep\/14.6.1493","article-title":"The differential risk of oral contraceptives: the impact of full exposure history","volume":"14","author":"Lewis","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analysis","volume":"323","author":"Kemmeren","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/bmj.324.7337.561","article-title":"Claim launched against makers of third generation pill","volume":"324","author":"Dyer","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/bmj.325.7358.237","article-title":"Judge dismisses test case on third generation pill","volume":"325","author":"Dyer","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib24","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1111\/j.1538-7836.2004.00983.x","article-title":"Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate","volume":"2","author":"van Vliet","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.jclinepi.2009.01.006_bib25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1538-7836.2008.02863.x","article-title":"Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor","volume":"6","author":"van Vliet","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib26","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib27","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/01.AOG.0000279448.62221.a8","article-title":"Risk of thromboembolism in women taking ethinylestradiol\/drospirenone and other oral contraceptives","volume":"110","author":"Seeger","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jclinepi.2009.01.006_bib28","article-title":"Papers that shaped pharmacoepidemiology","volume":"vol. 6","year":"2006"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435609000183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435609000183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T16:23:13Z","timestamp":1545322993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435609000183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0895435609000183"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2009.01.006","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}